BioNTX is celebrating a year of innovation, growth, and achievement across North Texas’ life science ecosystem with recognition of eight North Texas startups as 2025 Rising Stars. For demonstrating extraordinary leadership and scientific innovation, the companies were honored at BioNTX’s flagship iC³ Life Science & Healthcare Innovation Summit in September, culminating in the recent Rising Star Investor Dinner.
The Rising Stars program is designed to elevate emerging companies by providing visibility, credibility, and direct access to investors, industry leaders, and strategic partners, BioNTX said, and serves as a tailored pathway to connect top innovators to the region’s broader life science ecosystem.
“The Rising Stars program exemplifies the energy, creativity, and ambition that make our region a national leader in life sciences,” BioNTX CEO Kathleen Otto-Rosenblum said in a statement. “By connecting these innovators with investors and partners, we aren’t just recognizing their success—we’re accelerating it. This platform is a catalyst for growth, collaboration, and real-world impact.”
The 2025 Rising Stars were first recognized in September on the main stage at iC³, where they were introduced to an audience of investors, corporate leaders, researchers, and policymakers. That recognition was followed by the Rising Star Investor Dinner, which brought together current and past Rising Stars and investors for meaningful conversation, networking, and another opportunity to present their company.
2025 BioNTX Rising Star Recipients
- EidoBio – advancing precision medicine tools to unlock new possibilities in diagnostics and treatment for women’s health
- Metaclipse Therapeutics – pioneering immune-based therapies for cancer and infectious diseases
- Moleculera Biosciences – leading the way in neuro-immune diagnostics to improve brain health and patient outcomes
- ParaNano Wound Care – developing next-generation antimicrobial nanotechnologies to fight infection and accelerate healing
- Stingray Therapeutics – driving innovation in oncology with novel approaches to modulating the immune system
- StitchLock – transforming surgical care with breakthrough wound closure technology
- SyntaxisBio – engineering advanced biologics and therapeutics with scalable, real-world applications
- Telos Biotech – redefining gene and cell therapy platforms with bold new approaches to delivery and safety
Through Rising Stars, BioNTX said it focuses on investor exposure, ecosystem integration, and sustained engagement, ensuring companies are celebrated, supported, and primed for growth. Participants gain access to curated introductions, high-profile platforms, and relationship-building opportunities that extend well beyond a single event.
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.
R E A D N E X T
-
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
-
The BMW Dallas Marathon is gearing up for its 2025 race weekend, to be held in a long, winding course around White Rock Lake December 12–14. One way it's doing that is by unveiling "a bold new logo" featuring a modern take on the Pegasus—Dallas' celebrated icon—stretching its neck out toward victory. Along with a refreshed merchandise collection, the updated visual identity "reflects the organization’s evolution as a premier running event and its deep connection to the Dallas community," organizers said.
-
Dozens of sessions. Four signature summits. Hundreds of speakers. DFW Startup Week 2025 kicks off next week, and here’s how to make the most of it.
-
Top executives at Nasdaq and Susser Bank celebrated high-growth potential companies contributing to region’s rise in entrepreneurship and innovation
-
![The 2025 Southwest winners and stakeholders gather on stage at the EY Entrepreneur of the Year awards last weekend. [Photo via Dennis Cail]](https://s24806.pcdn.co/wp-content/uploads/2025/06/EY-southest-award-2025-Dennis-Cail-share.jpg)
The 2025 EY Entrepreneur Of The Year Southwest Awards were judged by a powerhouse panel of past winners—including Zirtue's Dennis Cail. What he saw in the 18 standout founders and executives? The grit and vision it takes to make it.
